UNSPSC 51201575: Ixekizumab

Injectable medication for the treatment of autoimmune diseases. Chemically, it is a form of a humanized monoclonal antibody. The substance acts by binding interleukin 17A and neutralizing it, reducing inflammation

UNSPSC 51201575 Ixekizumab, a Commodity code, does not reflect the work state and local governments are actually buying under this code designation. The recent opportunities tagged to this code span pharmaceutical services contracting, drug-distribution vending systems, forensic drug-standard reference materials, naloxone and drug-deactivation procurement, and regional trade shows—none of which involve ixekizumab, a monoclonal antibody therapeutic agent for inflammatory dermatologic conditions. The code designation appears to be a data-classification error rather than a meaningful category for state and local procurement activity. No recent solicitations actually solicit ixekizumab acquisition or related pharmaceutical manufacturing, warehousing, or supply-chain services under this code.

State and local issuing bodies posting under this code in the past four months include Dane County (comprehensive pharmacy services for a long-term care facility under RFP), Collier County (a single-source mobile medication-calculation application for EMS), West Texas Centers for Mental Health and Mental Retardation (prescription and pharmacy services across 35 sites), the City of Tucson Fire Department (BLS/ALS pharmaceuticals and vending systems under a federally funded IFB), Seminole County (naloxone and drug-deactivation systems under IFB), the District of Columbia (pharmacy benefits program network under RFQ), and Pinellas County (forensic drug reference standards under ITQ). Geographic activity spans Florida, Wisconsin, Texas, Arizona, Oregon, Kentucky, California, and the District of Columbia. Because this code's nominal scope and the recent-opportunity mix are unaligned, firms pursuing state and local procurement should verify code assignments before investing business development effort; the code as currently applied does not represent a coherent purchasing category.